VIVUS introduces Qsymia in UAE to treat overweight and obesity in adults and paediatric patients, age 12 and older
VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, announced the market approval of Qsymia (phentermine and …